Who are Yiqi Huoxue Huatan granule's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/yiqi-huoxue-huatan-granule.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

Yiqi Huoxue Huatan granule — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Yiqi Huoxue Huatan granule (Yiqi Huoxue Huatan granule) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Cardiovascular / Respiratory (TCM-based).

phase 3 Cardiovascular / Respiratory (TCM-based) Small molecule Live · refreshed every 30 min

Target snapshot

Yiqi Huoxue Huatan granule (Yiqi Huoxue Huatan granule) — Peking University People's Hospital. A traditional Chinese medicine granule formulation that aims to improve qi circulation, promote blood flow, and resolve phlegm/sputum accumulation.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Yiqi Huoxue Huatan granule TARGET	Yiqi Huoxue Huatan granule	Peking University People's Hospital	phase 3

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Yiqi Huoxue Huatan granule — Competitive Intelligence Brief. https://druglandscape.com/ci/yiqi-huoxue-huatan-granule. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab